References
1. Choi, Y.J., et al., Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19. Eur Respir J, 2020.
2. Colombo, C., et al., Impact of COVID-19 on people with cystic fibrosis. The Lancet Respiratory Medicine, 2020. 8 (5): p. e35-e36.
3. McClenaghan, E., et al., The global impact of SARS-CoV-2 in 181 people with cystic fibrosis. Journal of Cystic Fibrosis, 2020.
4. Green, I., et al., COVID-19 Susceptibility in Bronchial Asthma. J Allergy Clin Immunol Pract, 2020.
5. Lu, X., et al., SARS-CoV-2 Infection in Children. N Engl J Med, 2020. 382 (17): p. 1663-1665.
6. Castagnoli, R., et al., Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr, 2020. 174 (9): p. 882-889.
7. Patel, N.A., Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol, 2020. 41 (5): p. 102573.
8. Ludvigsson, J.F., Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr, 2020. 109 (6): p. 1088-1095.
9. Sanna, G., et al., Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr, 2020.179 (7): p. 1079-1087.
10. Williams, N., et al., COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities. Eur J Pediatr, 2021.180 (3): p. 689-697.
11. Götzinger, F., et al., COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health, 2020. 4 (9): p. 653-661.
12. Chao, J.Y., et al., Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. J Pediatr, 2020. 223 : p. 14-19 e2.